The global intra-abdominal pressure measurement devices market size was valued at USD 108.2 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 7.9% from 2020 to 2027. High prevalence of Intra-abdominal Hypertension (IAH) and Abdominal Compartment Syndrome (ACS) among ICU patients as well as adoption of technologically advanced products are the major factors expected to drive the market for intra-abdominal pressure measurement devices. Intra-abdominal hypertension refers to a pressure greater than 12 mmHg and is based on the pressure at which organ dysfunction occurs. The normal Intra-abdominal Pressure (IAP) for critically ill adults should range between 5-7 mmHg.
IAH is mainly caused by too much intra-abdominal volume within the abdominal cavity. In addition, elevated IAP occurs more often in patients suffering from acute abdominal syndromes such as intestinal perforation, peritonitis, ileus, acute pancreatitis, or trauma.IAPMD is used to measure IAP to identify individuals at the risk of IAH/ACS. There is high prevalence of IAH/ACS among patients in intensive care units across the world. The incidence of IAH and ACS is associated with significantly increased mortality and morbidity. The rise in intra-abdominal pressure causes tissue hypoperfusion which can lead to impaired hepatic blood flow, multiple organ dysfunction syndromes, respiratory failure, increased intracranial pressure, renal failure, and impair the function of nearly every organ. For instance, according to the article published in the Critical Care Medicine Journal in 2019, 38-45% of the patients develop intra-abdominal hypertension who are treated in ICU settings. Thus, increasing demand for intra-abdominal pressure measurement devices for early recognition and treatment of IAH and ACS are majorly driving the market.
Several initiatives are being undertaken by various organizations for the awareness related to real-time measurement of IAH in ICU patients. For instance, the World Society of the Abdominal Compartment Syndrome (WSACS) is an international not-for-profit organization consists of group of worldwide surgeons and physicians who promotes research, encouraging education, and revamping the treatment of patients with IAH/ACS. Moreover, in 2019, WSACS has organized 9th WCACS congress Campinas on Abdominal Compartment, in Brazil to increase partnerships around the world and focus on the treatment and management of abdominal compartment. This growing awareness among people regarding the treatment and initiatives taken by government to prevent the rate of associated disorders is likely to boost the growth of the market for intra-abdominal pressure measurement devices.
Countries such as the U.S. and Canada have witnessed increasing cases of ICU admissions and urological disorders such as interstitial cystitis, bladder cancer, prostate cancer, and bowel syndrome in the recent years. As per the Society of Critical Care Medicine (SCCM) 2019, in the U.S. approximately 5.0 million patients are admitted to ICUs for invasive or intensive monitoring every year. Furthermore, according to the Canadian Cancer Society Statistics 2020, it is estimated that in 2020, 23,300 men will be diagnosed with prostate cancer. Therefore, increasing prevalence of IAH and ACS among ICU patients and associated disorders is anticipated to boost the growth of the market for intra-abdominal pressure measurement devices over the forecast period.
Additionally, increasing number of cases of IAH and ACS in the developed and developing countries has driven the launch of technologically advanced products in the market for intra-abdominal pressure measurement devices. For instance, Potrero Medical’s Accuryn Monitoring System which is next generation diagnostic tool helps to precisely monitor patients' vital signs in real-time and integrates with the hospital Electronic Medical Record (EMR) system. This system can transform a traditional Foley catheter into a next-generation diagnostic tool that can automatically measure urine output, intra-abdominal pressure, and core body temperature. In addition, ConvaTec’s AbViser AutoValve intra-abdominal pressure monitoring device automatically integrates with all Foley catheters, transducers, and patient monitors in any ICU or operation room. Thus, market players are making constant efforts for introducing technologically advanced products in the market for intra-abdominal pressure measurement devices.
The equipment segment has dominated the market for intra-abdominal pressure measurement devices with a revenue share of 65.1% in 2019. As intra-abdominal hypertension measurement via indirect methods (equipment) has been considered as the gold standard method and has achieved widespread acceptance due to its simplicity and cost effectiveness. Technologically advanced monitors are used to help surgeons to closely monitor the patient and provide efficient treatment with IAH. Thus, benefits offered by the equipment segment are expected to fuel the growth of the market for intra-abdominal pressure measurement devices.
However, the disposables segment is expected to grow at the highest CAGR of 8.1% from 2020 to 2027. As sometimes indirect measurement via equipment is not feasible in some patients with bladder trauma, outflow obstruction, and neurogenic bladders which will require direct IAP measurement through disposables such as, intraperitoneal catheter, tubing pumps, and needles. Thus, the increasing application of disposables devices for the real time monitoring of intra-abdominal pressure is anticipated to boost the growth of the market for intra-abdominal pressure measurement devices in the forecast period.
The abdomen segment has dominated the intra-abdominal pressure measurement devices market with a revenue share of 76.9% in 2019. This is attributed to the increasing cases of intra-abdominal hypertension in critically ill patients. As elevated intra-abdominal pressure affects the organ functionality in such patients, and this may lead to abdominal compartment syndrome. IAH measurement is obtained by direct needle puncture within the abdominal cavity. Thus, these factors are anticipated to increase the demand for intra-abdominal pressure measurement devices during the forecast period.
Whereas, the muscle segment is expected to grow at a highest CAGR of 8.3% in the market for intra-abdominal pressure measurement devices from 2020 to 2027. This is attributed to the increasing cases of trauma, burns, abdominal surgeries, and sports injuries. This results in large amount of pressure inside a muscle compartment causes pain, swelling, and sometimes disability in the affected muscles. Thus, these factors are expected to increase the demand for intra-abdominal pressure measurement devices during the forecast period.
Intra-abdominal hypertension segment has dominated the market for intra-abdominal pressure measurement devices with a revenue-share of 91.6% in 2019 and is also expected to grow at the highest CAGR of 8.0% from 2020 to 2027. As IAH directly affects the abdominal organs such as liver and kidney, it may also affect the function of brain, lungs, and cardiovascular system. Patients receiving mechanical ventilation are more likely to have IAH. Thus, increasing ICU admissions is expected to boost segment growth in the coming years.
In addition, IAH frequently occurs in patients suffering from acute abdominal syndromes such as peritonitis, ileus, intestinal perforation, acute pancreatitis, or trauma. Several other factors such as surgical and medical factors are responsible for increased intra-abdominal hypertension. Surgical factors include omphalocele, postoperative hemorrhage, ileus, gastroschisis, primary trauma, or burns. Other factors that may induce IAH include acute pancreatitis, edema, acute respiratory failure with raised intra-thoracic pressure, and intra-abdominal tumor. Thus, increasing prevalence of acute abdominal syndromes and surgical procedures induces the IAH, which in turn, is expected to drive the segment.
North America dominated the market with a share of 60.2% in 2019. This is attributable to the presence of well-established healthcare facilities in the region, increasing government initiatives, and rising cases of ICU admissions. Furthermore, availability of technologically advanced products and presence of major key players such as BD, C2DX, Inc, and Medline Industries are also contributing towards the growth of the market for intra-abdominal pressure measurement devices in the region.
Asia Pacific is expected to grow at a highest CAGR of 8.8% from 2020 to 2027 due to the factors such as growth in aging population, huge population base, and unmet needs regarding the IAH diagnosis and treatment in this region. Moreover, improvements in clinical development framework of developing economies such as Japan, India, and China are likely to contribute to the growth of the market for intra-abdominal pressure measurement devices.
The key market players are focusing on the launch of innovative types of medical devices, technological advancements, and growth strategies. For instance, in June 2019, C2Dx Inc. has acquired a product line called ‘Intra-Compartmental Pressure Monitoring System’ from Stryker Corporation. It is also known as the STIC Monitor which is considered as the gold standard tool for diagnosing and management of chronic and acute compartment syndrome. These advancements in the area of market are anticipated to boost the growth of the market for intra-abdominal pressure measurement devices over the forecast period. Some of the prominent players in the intra-abdominal pressure measurement devices market include:
C. R. Bard, Inc. (BD)
Convatec Group Plc
Potrero Medical
Biometrix
Holtech Medical
Gaeltec Devices Ltd.
Speigelberg GmbH & Co. KG.
C2Dx Inc.
Centurion Medical Products (Medline Industries, Inc.)
Report Attribute |
Details |
Market size value in 2020 |
USD 116.3 million |
Revenue forecast in 2027 |
USD 197.5 million |
Growth rate |
CAGR of 7.9% from 2020 to 2027 |
Base year for estimation |
2019 |
Historical data |
2016 - 2018 |
Forecast period |
2020 - 2027 |
Quantitative units |
Revenue in USD million and CAGR from 2019 to 2027 |
Report coverage |
Revenue, competitive landscape, growth factors, and trends |
Segments covered |
Product, procedure, application, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; China; India; Australia; South Korea; Brazil; Mexico; Colombia; Argentina; South Africa; Saudi Arabia; UAE |
Key companies profiled |
C. R. Bard, Inc. (BD); Convatec Group Plc; Potrero Medical; Biometrix; Holtech Medical; Gaeltec Devices Ltd.; Speigelberg GmbH & Co. KG.; C2Dx Inc.; Centurion Medical Products (Medline Industries, Inc.) |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the global intra-abdominal pressure measurement devices market report on the basis of product, procedure, application, and region:
Product Outlook (Revenue, USD Million, 2016 - 2027)
Disposables
Equipment
Procedure Outlook (Revenue, USD Million, 2016 - 2027)
Abdomen
Muscle
Application Outlook (Revenue, USD Million, 2016 - 2027)
Intra-compartment Pressure
Intra-abdominal Hypertension
Regional Outlook (Revenue, USD Million, 2016 - 2027)
North America
The U.S.
Canada
Europe
Germany
The U.K.
France
Italy
Spain
Asia Pacific
Japan
China
India
Australia
South Korea
Latin America
Brazil
Mexico
Argentina
Colombia
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
b. The global intra-abdominal pressure measurement devices market size was estimated at USD 108.16 million in 2019 and is expected to reach USD 116.30 million in 2020.
b. The global intra-abdominal pressure measurement devices market is expected to grow at a compound annual growth rate of 7.9% from 2020 to 2027 to reach USD 197.45 million by 2027.
b. North America dominated the intra-abdominal pressure measurement devices market with a share of 37.33% in 2019. This is attributable to the presence of well-established healthcare facilities in the region, increasing government initiatives, and rising cases of ICU admissions.
b. Some key players operating in the intra-abdominal pressure measurement devices market include C. R. Bard, Inc. (BD), ConvaTec Group PLC, C2Dx Inc., Medline Industries, Holtech Medical, Biometrix Ltd., Spiegelberg GmbH, Potrero Medical Inc., Gaeltec, and Millar.
b. Key factors that are driving the market growth include high prevalence of IAH and ACS among patients in intensive care units (ICUs) across the world as well as rapid technological advancements in intra-abdominal pressure measurement devices.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
We value your investment and offer free customization with every report to fulfil your exact research needs.